Health-care providers wrote more than 9 million prescriptions for Ozempic and similar drugs in the final three months of 2022, according to a new analysis of medications that have become highly ...

A diabetes medication in short supply for the last two years often was prescribed to people who didn't have the disease, and prescribing rates varied dramatically across the country, new data shows.

A shortage and user error are being blamed for a massive spike in calls to the Utah Poison Control Center over weight loss ...

Page Six exclusively spoke with a registered dietitian about the safety and efficiency of the “Kardashians” star’s latest ...

You don't often see a "science day" in a Philadelphia courtroom. But that's exactly what happened last week in a potentially ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn’t ...

Analysts believe Hims & Hers will earn $0.57 per share this year and $0.80 next year. That prices the stock at 17 times next ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.

Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.

Inflation might be easing in some segments of the economy, but health care costs are set to soar next year ... increased expenditures on specialty prescription drugs — particularly GLP-1 ...

(NEXSTAR) – A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat ... runny nose and sore throat. While other gastrointestinal issues are mentioned in the 15-page ...